GLP-2T

GLP-2T (LY3298176)

Research-Grade Dual Incretin Agonist
Tagline: Metabolic & Weight Management Research

Product Description

GLP-2T (scientific designation LY3298176) is a novel, long-acting dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This unique combination makes GLP-2T an important research tool for studying glucose regulation, weight management, and metabolic disease models.

Researchers use GLP-2T to investigate insulin secretion, appetite regulation, gastric emptying, and fat metabolism in preclinical and clinical studies. Its dual-incretin activity allows exploration of synergistic effects on glycemic control and energy balance.

For Laboratory and Scientific Research Use Only. Not for Human Consumption.

Why Researchers Choose GLP-2T

• Dual Receptor Agonism: Simultaneously activates GLP-1 and GIP receptors for broader metabolic effects.

• High Purity: ≥98% purity ensures reproducible data.

• Long-Acting Design: Weekly dosing models possible due to extended half-life.

• Research Relevance: Widely studied for obesity, diabetes, and cardiovascular risk reduction.

• Batch Verified: Each lot tested for identity, potency, and structural integrity.

Important Note

For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.Tirzepatide